INTRODUCTION
DUE ensures safety and efficacy of drugs to improve patient's health status. It also promotes the rational use of drugs and reduces health care cost. 1, 2, 3 It is a vital component of clinical pharmacy practice. 4, 5, 6 DUE is a framed process which could be used for analysing the pattern of drug usage in various healthcare settings. Conducting DUE studies also contribute to reducing healthcare cost and incidence of adverse drug events. 7, 8 For the comparison of drug utilization among various departments or among various healthcare Settings, WHO launched a technical unit of measurement in conjunction with the Anatomic Therapeutic Chemical classification which is referred as Defined Daily Dose (DDD). The World Health Organization Anatomical Therapeutic Chemical / Defined Daily Dose (WHO ATC/DDD) has been accepted as a gold standard and is used by researchers for calculating the drug consumption throughout the world.
DDD is the presumed average daily dose for a drug prescribed for its prior indication in adults. It doesn't give an exact picture of the drug consumption but provide a rough estimate of the drug usage. DDD is independent of the dosage form and cost thus enabling the researchers for the assessment of trends in drug utilization. DDD is a potent tool for comparing the drug utilization. The goal of calculating DDD is to improve drug usage. 9 The WHO ATC/DDD transcribes dosage forms of drugs (tablets, vials, capsules, inhalers etc.) to a standard unit called DDD. Usually DDD's are assigned for those drugs which are marketed and approved in at least one country and DDD is not assigned for those medicines which are used in rare disorders or diseases, dermatology, vaccines, anesthetics, sera and contrast media.
10
Colistin, Teicoplanin and Tigecycline are the High end restricted antibiotics mostly used for the treatment of MDR (Multi Drug Resistance) infections. Among them Colistin is active against G negative organisms, teicoplanin against G positive organisms and tigecycline is active against both G positive and G-negative organisms. The purpose of our study was to evaluate the appropriateness of the usage of these antibiotics, then to value their indication for use in different wards, to determine the de-escalation process based on culture report and to calculate the defined daily dose for these antibiotics in the study period and compare the drug utilization in different departments. Data's were collected from the case sheets of Inpatients who were treated with colistin, teicoplanin and tigecycline.
OBJECTIVES
To evaluate the indication for use of Colistin, tigecycline and teicoplanin in different wards.
To evaluate the de-escalation process based on culture report.
To calculate the defined daily dose for these antibiotics during the study period and to compare the drug utilization in different departments
Study Design
A prospective observational study on drug utilization pattern of Colistin, Teicoplanin and Tigecycline was conducted in G. Kuppusamy Naidu Memorial Hospital, Coimbatore with a sample size of 103 patients.
Inclusion and Exclusion Criteria
All inpatients receiving Teicoplanin, Tigecycline and Colistin during the study period from February 2016-July 2016 were included in the study. We excluded the inpatients who discharged against medical advice.
Method of Data Collection
During our study, we reviewed the case sheets of all patients who met the inclusion criteria. Data was collected using a well-structured data collection proforma which includes patient's demographics, drug allergies, patient's case history, medication chart, culture reports and laboratory parameters. We reviewed the laboratory parameters regularly to check any variations. The culture and sensitivity reports were analyzed to assess the appropriateness of the antibiotic selection. Any medication errors that were found in our cases were also recorded. Follow up of de-escalation process was done and the usage of Colistin, teicoplanin and tigecycline was calculated using DDD. All the discrepancies observed have been documented appropriately in the data collection form designed for our study.
Data Analysis
The data was analyzed using Graph pad version 5.03. Chi square test was used to analyze the drug utilization in various departments, its indication for use and the deescalation process. A p-value of ≤ 0.05 was considered to be significant. Using this value the significance for our results was calculated.
RESULTS AND DISCUSSION
In our study, we collected details from 103 patients, who were treated with Colistin, Teicoplanin and Tigecycline and found that Colistin was mostly used and majority of patients were male (81.53%) as compared to females (18.46%) Table 1 . Mostly these antibiotics were prescribed in the age group of 51-70yrs, among them Colistin was prescribed frequently i.e. nearly 32.81% (n=21) followed by age group 29.68% (n=19) The spread of MDR micro-organisms is a global threat. Compared to previous years, the number of microorganisms isolated is increasing tremendously. During our study, Klebsiella species have been isolated mostly in the cultures, nearly 27.08% (n =26) We also determined that the sec most frequently isolated organism was Acinetobacter baumannii 18.75% (n=18) Table 4 and like Klebsiella species, Acinetobacter was also treatable with Colistin. Gary Martens et al., in 2009 also studied the distribution pattern of organism and finalized that in-spite of the risk of nephrotoxicity, Colistin is highly efficacious to multi-drug resistant Acinetobacter baumannii infections.
Resistant mechanisms observed in our study was Carbapenem resistance 60.31% (n=38), ESBL 26.98% (n=17), methicillin resistance 11.11% (n =7) and Colistin resistance 1.58% (n =1) From our study we concluded that proper de-escalation of restricted antibiotics was not performed in 86.40% (n=89) Table 5 cases and a similar study was conducted by Garnacho -Montero. J et al., in 2015 concluded that antibiotic de-escalation is a well-tolerated management strategy in critically ill patients but unfortunately is not widely adopted.
We concluded that the use of restricted antibiotic was almost the same in all wards, 50.48% (n=52) and ICU 49.51% (n=51) Figure 1 and better outcome was seen with the use of these antibiotics. A similar study was conducted by Michalopoulos. A. S et al., in 2004 which indicated that Colistin was mostly used in ICU setups in critically ill patients and showed good clinical response.
For the comparison of drug utilization among various departments, WHO launched a technical unit of measurement in conjunction with the anatomic therapeutic chemical classification which is referred as DDD. We calculated DDD of these antibiotics and found its usage in ICU and wards. Colistin was used most 
CONCLUSION
Antibiotics are most widely prescribed for majority of the patients at the time of admission. Antibiotics continue to be widely prescribed in critically ill patients and form a significant proportion of the total drug consumed in the ICU's. A serious bacterial infection requires prompt and appropriate treatment to minimize the cost of treatment, length of hospital stay and the risk of morbidity and mortality. To achieve this goal, broad-spectrum antibiotics are recommended as initial empirical therapy, followed by streamlining to a more specific therapy after receiving Culture reports. This minimizes the development of antibiotic resistance.
Our study shows that implementation of an antibiotic order form for restricted antibiotics and follow up by frequently, 82.54 % (202.720 g), followed by Tigecycline 13.41 (32.946 g) and Teicoplanin 4.03 (9.917 g) Figure 2 .
clinical pharmacists can lead to marked reduction in antibiotic usage, improved, appropriate and effective use of antibiotics. This research work emphasizes the strict regulation are essential to promote rational use. We found that Colistin was mostly prescribed out of these three restricted antibiotics for neutropenic condition followed by respiratory tract infections. The usage statistics of these three restricted antibiotics in various departments was analyzed which showed that Colistin was in most of the cases, de-escalation was not done even though, only half of them had MDR strains (50.8%). These restricted antibiotics were given for other conditions. These restricted antibiotics were given for other conditions other than MDR strains including neutropenic conditions in cancer patients and also for pre-term conditions. In such scenario as well de-escalation was not found in practice (22.5%). If proper de-escalation is not done, it may result in increased emergence of antimicrobial resistance and lead to increased health care cost.
14, 15, 16, 17, 18, 19, 20, 21 The medication related problems associated with these three restricted antibiotics was low during the study period.
The consumption of the Colistin, tigecycline and teicoplanin in various departments was calculated based on DDD which revealed that Colistin was highly consumed compared to tigecycline and teicoplanin.
A stewardship Program must be implemented in the hospital to improve overall antibiotic usage in hospital. By this, we could reduce the emergence of antibiotic resistance up to a certain extent. If not there won't be any choice of antibiotic for the treatment of MDR infections. By implementing this, we could promote the rational use of drugs, reduce hospital stay, minimize health care cost and prevent medication related problems.
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